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against ischemia/reperfusion injury in rats
Zhaojun Qin, En Lv*, Leyun Zhan, Xiangfei Xing, Jianli Jiang and Min ZhangAbstract
Background: Emulsified isoflurane (EIso) is a novel intravenous general anesthetic, which can provide rapid
anesthetic induction and recovery. EIso preconditioning could attenuate heart, lung and liver ischemia/reperfusion
(I/R) injury. We tested the hypothesis that intravenous pretreatment with EIso would protect kidneys against I/R
injury by inhibiting systemic inflammatory responses and improving renal antioxidative ability.
Methods: Rats were randomly divided into these six groups: sham, I/R, intralipid, 1, 2 or 4 ml/kg EIso. Rats were
subjected to 45 min left renal pedicle occlusion followed by 3 h reperfusion after right nephrectomy. Rat were
treated with intravenous 8% EIso with 1, 2 or 4 ml/kg, or 30% intralipid with 2 ml/kg for 30 min before ischemia,
respectively. After reperfusion, renal functional parameters, serum mediator concentrations and markers of oxidative
stress in kidney tissues were determined, and renal histopathological analysis were performed.
Results: Serum creatinine, blood urea nitrogen, cystatin c, tumor necrosis factor-α, interleukin-6, and interleukin-10
concentrations were significantly increased after renal I/R as compared to the sham group. So was renal tissue MDA
content and histological scores, but renal tissue SOD activity was decreased. Additionally, severe morphological
damages were observed in these study groups. In contrast, 2 or 4 ml/kg EIso reduced serum creatinine, blood
urea nitrogen, cystatin c, tumor necrosis factor-α, and interleukin-6 levels, decreased renal tissue MDA content and
histological scores, increased serum interleukin-10 level and tissue SOD activity as compared to the I/R, intralipid
and 1 ml/kg EIso groups. Renal morphological damages were alleviated after pretreatment of 2 or 4 ml/kg EIso.
Conclusions: Intravenous EIso produces preconditioning against renal I/R injury in rats, which might be mediated
by attenuating inflammation and increasing antioxidation ability.
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Ischemia/reperfusion (I/R) injury is an important cause
of intrinsic acute kidney injury in both allograft and na-
tive kidney [1], which accounts for high mortality and
morbidity in patients [2]. Improving the ability of the
kidney to tolerate I/R injury would have important implica-
tions. An increasing number of drugs, including inhala-
tional anesthetics, have a pharmacological preconditioning
effect in organs [3-8] as ischemic preconditioning. Inhaled
isoflurane was showed to reduce acute renal injury induced* Correspondence: ycyyluen@126.com
Department of Anesthesiology, Three Gorges University People’s Hospital,
Yichang, China, No. 4, Hudi Street, Xiling District, Yichang 443000, Hubei,
People’s Republic of China
© 2014 Qin et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.by I/R, and the mechanisms involved anti-inflammation
[9], the inhibition of protein kinases [10], the activation of
adenosine triphosphate-dependent potassium channels [9],
the release of renal tubular transforming growth factor-β 1
[7], ecto-5′-nucleotidase (CD73) and adenosine [11], and/
or the upregulation of hypoxia inducible factor-1 α [12].
The overall mechanism of organ protection by volatile an-
esthetics is likely to be multifactorial [13,14], and it has
been the focus of intense investigation.
Emulsified isoflurane (EIso) is a novel intravenous gen-
eral anesthetic, which has been the subject of recent re-
search because it was found to eliminate the need for
specific ventilatory circuits, provide rapid anesthetic in-
duction and recovery, have remarkable hemodynamic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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toxicity [16]. It can be administered intravenously rather
than as an inhalant. It is easier to control the depth of
anesthesia than isoflurane inhalation. Rao et al. [17]
demonstrated that 8% EIso had a myocardial protective
effect on I/R injury similar to that of inhaled isoflurane
in rabbits. It is also showed that intravenous pretreat-
ment with 2 or 4 ml/kg EIso affords effective protection
against myocardial ischemia in rats by inhibiting apop-
tosis [15]. Lv et al. [18] demonstrated that EIso reduced
lung injury induced by hepatic I/R by decreasing tumor
necrosis factor-α (TNF-α) level and down-regulation of
intercellular adhesion molecule-1 in the lung tissue. Re-
cently, it was reported that EIso postconditioning could
produce cardioprotection against myocardial I/R injury
in rats by the inhibition of apoptosis [19] and the preser-
vation of mitochondrial function [20]. Whether EIso ad-
ministered before ischemia could protect kidneys against
reperfusion injury remains unknown.
Therefore, we have hypothesized that EIso could protect
the kidney against I/R injury by inhibiting systemic inflam-
matory responses and improving renal antioxidative abil-
ity. In this study we set out to examine the effects of
different preconditioning doses on renal I/R injury, and
systemic mediators release and oxidative stress reaction in
the model of renal I/R injury in rats. We measured renal
functional parameters, serum mediators involved in in-
flammation, markers of oxidative stress in kidney tissues
and outcome of acute renal I/R injury.
Methods
Animal preparation
Animals were treated according to the Guidelines of
Animal Experiments from the Committee of Medical
Ethics, National Health Department of China and with
approval of the Institutional Animal Care and Use Com-
mittee of Wuhan University. Adult male Sprague Dawley
rats weighing 220–300 g were obtained from the Animal
Experiment Centre of Wuhan University. Rats were accli-
mated for 1 week before experiments, with unrestricted
access to water and food.
Following a 12 h fasting period, rats were anesthetized
with 1% sodium pentobarbital (Sigma Chemical Company,
St. Louis, MO, USA) 5 ml/kg given intraperitoneally.
Anesthesia was maintained by intravenous 1% sodium
pentobarbital 1–2 ml/kg. During surgical procedures, rats
were supine on a heating pad and body temperature was
maintained at 36–38°C. A 24 gauge venous catheter was
inserted into the right jugular vein, and Ringer’s lactate so-
lution was administered at a bolus dose of a 0.5 ml and
continued as an infusion at 8 ml/kg/h. Acute renal ische-
mia was established as described previously [9]. Briefly,
after a midline laparotomy and right nephrectomy, left
renal ischemia was induced by unilateral renal pedicleclamping for 45 min with an atraumatic microaneurysm
clamp. After 45 min of left renal ischemia, the occlusion
clip was removed and renal reperfusion was allowed. Suc-
cessful renal ischemia is defined as the color of kidney is
changed from bright red to dark red; on the contrary, suc-
cessful renal reperfusion is defined as the color is changed
from dark red to bright red.
Preparation of EIso
EIso (8% vol./vol.) was manufactured by Yichang Human-
well Pharmaceutical Co. Ltd (Yichang, China) according
to the procedures described previously [21], which was
kindly donated by Prof. Jin Liu from the Laboratory of
Anesthesiology and Critical Care Medicine, West China
Hospital, Sichuan University (Chengdu, China). Briefly,
1.6 ml liquid isoflurane (Abbott Laboratories, Kent, UK)
and 18.4 ml 30% intralipid (fat emulsion injection, Huarui
Pharmaceutical Co., Ltd. Wuxi, China) was mixed in a
20 ml glass ampoule and sealed using an alcohol blow-
torch. The ampoule was then vigorously shaken on a vi-
brator for 15 min to solubilize isoflurane into a lipid
emulsion. The EIso ampoule was stored at 4°C until use.
The ampoule were opened and warmed to 37°C for 2 h
before intravenous administration. And the residual drug
was discarded. The stability of EIso was determined by gas
chromatography before the experiment (Aligent 4890 D;
Tegent Technology Ltd., Shanghai, China).
Experimental protocol
After stabilization, forty-two rats were randomly allocated
to the following six treatment groups: sham, I/R, intrali-
pid, and EIso groups (1, 2 or 4 ml/kg EIso).
Sham group (n = 7), Group S: animals were only
underwent right nephrectomy and exposured of the left
renal pedicles, but were not subjected to any I/R. No
additional medication was given, only a Ringer’s lactate
solution infusion was maintained.
I/R group (n = 7), Group I/R: the left renal I/R injury
models were induced as described above. No additional
medication was given, only a Ringer’s lactate solution
infusion was maintained.
Intralipid group (n = 7), Group I: 30% intralipid was
intravenously infused at a dose of 2 ml/kg for 30 min
before renal ischemia. Infusion was discontinued
15 min prior to the renal pedicle occlusion.
EIso groups (n = 7), Group EIso 1, 2 or 4 ml/kg: EIso
(8% vol./vol.) was intravenously administered at a
dose of 1, 2 or 4 ml/kg for 30 min prior to the renal
ischemia, respectively. Infusion was followed by a 15-min
washout period before the renal pedicle occlusion.
Blood samples were taken from the abdominal aorta
3 h after reperfusion. After blood samples were clotted
Table 1 Numerical scoring system used in the
histopathological evaluation of renal ischemia [22]
Grade Degree of the proximal convoluted tubule necrosis
0 Normal histology
1 Mitoses and necrosis of individual cells
2 Necrosis of individual cells in adjacent proximal
convoluted tubules, with survival of surrounding tubules
3 Necrosis confined to the distal third of the proximal
convoluted tubule with a band of necrosis extending
across the inner cortex
4 Necrosis affecting all three segments of the proximal
convoluted tubule
The numerical scoring system for the histopathological evaluation of renal
ischemia was first outlined by Jablonski et al. [22]. Histological assessment of
kidney slices stained with hematoxylin-eosin was performed by a pathologist
under a light microscope. Grade 0 indicates normal proximal convoluted
tubule, Grade 4 indicates severly damaged proximal convoluted tubule.
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immediately by centrifugation of 1000 g for 30 min at
4°C and stored at -70°C for biochemical analysis. Cre-
atinine (Cr), blood urea nitrogen (BUN) (Ningbo Rui
Biotechnology Co., Ltd. Ningbo, China) and cystatin c
(CYC) (Shanghai Jingyuan Medical Instruments Co.,
Ltd. Shanghai, China) were measured in serum with an
AU5400 autoanalyzer (Beckman, Tokyo, Japan). TNF-α,
interleukin-6 (IL-6) and IL-10 were measured in serum by
enzyme linked immunosorbent assay (ELISA) (Elabora-
tescience Biotechnology Co., Ltd. Wuhan, China), accord-
ing to the manufacturer guidelines.
At the end of the experiment animals were sacrificed
with an overdose sodium pentobarbital. The left kidneys
were bisected along the long axis and cut into two
equal-sized slices. Tissue sample from one half kidneys
was homogenized in 0.1 mol/L phosphate buffer (pH 7.4)
at a ratio of 1:10 weight for volume. After centrifugation
at 4,000 g for 5 min, the supernatant was extracted for
measurement of malondialdehyde (MDA) content and
superoxide dismutase (SOD) activity. As markers of oxida-
tive stress, MDA content was determined by the thiobar-
bituric acid method, whereas SOD activity was evaluated
according to the xanthine oxidase method. MDA con-
tent and SOD activity in renal tissue were measured
with a spectrometer using commercially available kits
(Jiancheng Biologic Project Co., Nanjing, China). Renal
tissue protein concentration was determined by the
bicinchoninic acid method (Beyotime Institute of Bio-
technology, Shanghai, China).
Another half kidney was fixed in a 4% neutral parafor-
maldehyde solution for 24 h. After automated dehydra-
tion through a graded alcohol series, transverse kidney
slices were embedded in paraffin. Five-micron-thick sec-
tions were cut by microtome, stained with hematoxylin-
eosin. A quantitative histological assessment under a light
microscope (BX50 Olympus; Toyko, Japan) was per-
formed by an experienced pathologist who was blinded to
the treatment conditions. A grading scales (scores of 0 to
4) for assessment of necrotic injury of the proximal tu-
bules was used for the histopathological assessment of
damage in each animal, as outlined by Jablonski et al. [22]
(Table 1). And then a mean score of each group was calcu-
lated (scores potentially ranging from 0–4).Statistical analysis
Data are presented as mean ± standard deviation. Statis-
tical analyses were performed by one-way analysis of
variance followed by the Student-Newman-Keuls test for
multiple comparisons. A value of P < 0.05 was consid-
ered statistically significant. All analyses were performed
using SPSS 18.0 statistical software (SPSS Inc., Chicago,
IL, USA).Results
Renal function parameters
Kidneys subjected to 45 min ischemia and 3 h reperfusion
significantly increased serum Cr, BUN and CYC concentra-
tions as compared to the sham group (P < 0.05) (Table 2).
Both 2 and 4 ml/kg EIso preconditioning markedly de-
creased serum Cr, BUN and CYC concentrations com-
pared with the I/R, intralipid and 1 ml/kg EIso groups
(P < 0.05) (Table 2). There were no significant differ-
ences between the 2 and 4 ml/kg EIso groups about
these renal function parameters (P > 0.05). Meanwhile,
no significant differences were observed in these param-
eters among the I/R, intralipid and 1 ml/kg EIso groups
(P > 0.05).
Markers of inflammation
Kidneys subjected to 45 min ischemia and 3 h reperfu-
sion significantly increased serum TNF-α, IL-6 and IL-
10 concentrations as compared to the sham group (P <
0.05) (Table 2). Both 2 and 4 ml/kg EIso pretreatment
markedly reduced serum TNF-α and IL-6 levels, but in-
creased serum IL-10 level, compared with the I/R, intra-
lipid and 1 ml/kg EIso groups (P < 0.05) (Table 2). No
significant differences were observed in the three pa-
rameters between 2 and 4 ml/kg EIso groups (P > 0.05).
There were no significant differences in the three pa-
rameters among the I/R, intralipid and 1 ml/kg EIso
groups (P > 0.05).
Markers of oxidative stress
Compared with the sham group, renal tissue MDA con-
tent was increased, and SOD activity was decreased after
kidneys were subjected to 45 min ischemia and 3 h re-
perfusion (P < 0.05) (Table 2). Compared with the I/R,
intralipid and 1 ml/kg EIso groups, both 2 and 4 ml/kg
EIso pretreatment markedly reduced renal tissue MDA
content, but increased SOD activity (P < 0.05) (Table 2).
Table 2 Renal functional parameters, markers of inflammation and oxidative stress
S I/R I EIso 1 ml/kg EIso 2 ml/kg EIso 4 ml/kg
Cr (μmol/L) 24 ± 5 98 ± 6* 94 ± 15* 96 ± 11* 61 ± 6*†‡§ 63 ± 3*†‡§
BUN (mmol/L) 6.5 ± 1.6 14.5 ± 4.7* 13.9 ± 4.5* 14.0 ± 3.5* 9.3 ± 2.3*†‡§ 9.6 ± 4.2*†‡§
CYC (mg/L) 1.35 ± 0.16 2.42 ± 0.27* 2.5 ± 0.15* 2.4 ± 0.24* 1.71 ± 0.10*†‡§ 1.87 ± 0.14*†‡§
TNF-α (pg/ml) 47.6 ± 1.0 121.0 ± 6.8* 114.9 ± 10.1* 120.2 ± 11.2* 80.5 ± 5.4*†‡§ 84.8 ± 7.7*†‡§
IL-6 (pg/ml) 36 ± 6 108 ± 9* 98 ± 6* 96 ± 4* 67 ± 6*†‡§ 71 ± 6*†‡§
IL-10 (pg/ml) 19 ± 6 57 ± 12* 57 ± 11* 67 ± 7* 85 ± 10*†‡§ 83 ± 7*†‡§
MDA (nmol/mg) 1.32 ± 0.19 2.05 ± 0.31* 1.91 ± 0.35* 1.98 ± 0.32* 1.61 ± 0.28*†‡§ 1.62 ± 0.17*†‡§
SOD (U/mg) 117 ± 10 78 ± 12* 79 ± 13* 80 ± 17* 97 ± 7*†‡§ 98 ± 10*†‡§
Serum concentrations of creatinine (Cr), blood urea nitrogen (BUN), cystatin c (CYC), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-10, and renal tissue
malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in rats in the sham (S), I/R, intralipid (I) and EIso groups (EIso 1, 2 or 4 ml/kg). Serum Cr,
BUN, CYC, TNF-α, IL-6, IL-10 concentrations and renal tissue MDA content were significantly increased, and renal tissue SOD activity was markedly decreased after
kidneys subjected to 45 min ischemia and 3 h reperfusion compared with the sham group. Compared with the I/R, intralipid and 1 ml/kg EIso groups, serum Cr,
BUN, CYC, TNF-α, IL-6 levels and renal tissue MDA content were significantly reduced, and serum IL-10 level and renal tissue SOD activity were markedly increased
after 2 or 4 ml/kg EIso pretreatment. Data represent mean ± SD. *P < 0.05 compared to S, †P < 0.05 compared to I/R, ‡P < 0.05 compared to I, §P < 0.05 compared to
EIso 1 ml/kg.
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and SOD activity between the 2 and 4 ml/kg EIso groups
(P > 0.05). No differences were observed in the two pa-
rameters among the I/R, intralipid and 1 ml/kg EIso
groups (P > 0.05).Renal histopathology
The degree of renal necrotic injury is most severe in the
proximal tubules located in the renal cortex area after
I/R injury. Therefore, we show this area in the figures.
Normal histological characteristic of glomeruli and tu-
bules, and no morphological damage was observed in
the kidneys of sham group (Figure 1A). Compared with
kidneys from the sham group, the kidneys in the I/R,
intralipid and 1 ml/kg EIso groups showed significant
renal damage demonstrated by severe tubular dilatation,
tubular epithelial cell swelling, vacuolar degeneration and
necrosis, many tubular epithelial cells sloughing from the
basement membrane, tubular luminal obstruction, and
interstitial hemorrhage and edema (Figure 1B-D). Rats pre-
treated with 2 or 4 ml/kg EIso showed marked reduction
of the histological features of kidney injury, consisting of
focal tubular necrosis and moderate interstitial hemorrhage
and edema (Figure 1E-F).
Compared to the sham group (0 ± 0), the histological
scores in the other five groups were higher (P < 0.05)
(Figure 1G). There were lower histological scores in the
2 and 4 ml/kg EIso groups (1.1 ± 0.7, 1.1 ± 0.6, respectively)
compared with the I/R (3.0 ± 0.5), intralipid (2.9 ± 0.5) and
1 ml/kg EIso (3.0 ± 0.4) groups (P < 0.05) (Figure 1G). No
differences were observed about the histological scores be-
tween the 2 and 4 ml/kg EIso groups (P > 0.05). There were
no differences in histological scores among the I/R, intrali-
pid and 1 ml/kg EIso groups (P > 0.05).Discussion
In the present study, we demonstrated that 2 ml/kg EIso
(8% vol./vol.) pretreatment alleviated renal tissue mor-
phological damage, decreased serum Cr, BUN, CYC,
TNF-α and IL-6 concentrations, reduced renal tissue
MDA content, increased serum IL-10 concentration and
tissue SOD activity in the I/R model of rat kidneys, as
4 ml/kg EIso pretreatment. Our results indicated that
EIso may exert protective effects against renal I/R injury
in rats by inhibiting systemic inflammatory response and
improving antioxidation of the tissue. To our knowledge,
this is the first study to show that intravenous adminis-
tration of EIso could produce renal protection.
Chiari et al. [23] found that intravenous infusion of 6.9%
EIso at a constant rate of 3.5 ml/kg per h for 30 min pro-
duces acute and delayed preconditioning against myocar-
dial infarction in rabbits. In the same way, intravenous
pretreatment of 2 or 4 ml/kg 8% EIso for 30 min affords
effective protection against myocardial ischemia in rats
[15]. And these doses of EIso had no significant inhibitory
effects on circulation function in pentobarbital anesthe-
tized rats [15]. Base on these studies, we demonstrated in
the present study that EIso (2 or 4 ml/kg for 30 min) is
useful for preventing renal injury after ischemia.
Measurement of serum Cr and BUN levels have been
used to determine renal function in many experimental
studies. Coll et al. [24] reported that serum concentra-
tion of CYC could reflect glomerular filtration rate very
accurately, even in cases where there was only a minor
reduction in glomerular filtration rate. A meta-analysis
of 46 CYC-related studies to evaluate the superiority of
CYC levels over serum Cr levels showed that serum CYC
is a more potent marker of glomerular filtration rate than
serum Cr [25]. Serum CYC level is a more sensitive test
for the early detection of renal function impairment or
Figure 1 Renal injury panels (A) to (F) are representative micrographs of optical microscopic analysis in the renal cortex of rats for the
sham (S), I/R, intralipid (I) and EIso groups (EIso 1, 2 or 4 ml/kg), respectively. Normal kidney tissue, normal histological characteristic of
glomeruli and tubules were observed in the sham group (A). In the I/R (B), intralipid (C) and 1 ml/kg EIso (D) groups, marked structural changes
were seen in kidney tissues. Arrow a and j indicate tubular dilatation; Arrow b, f and h indicate interstitial hemorrhage; Arrow c, d and i indicate
sloughing tubular epithelial cell necrosis; Arrow e indicates tubular epithelial cell vacuolar degeneration. Moderate kidney damages were showed
in the 2 (E) and 4 (F) ml/kg EIso groups. Arrow k and m indicate interstitial hemorrhage; Arrow l and n indicate sloughing tubular epithelial cell
necrosis. Original magnification × 400. Panel (G) represents Jablonski grade of histological appearance of acute tubular necrosis. The type and
severity of acute tubular necrosis was graded from 0 to 4 in each group of rats (see Table 1). Kidneys subjected to 45 min ischemia and 3 h
reperfusion increased Jablonski grade as compared to the sham group. Both 2 and 4 ml/kg EIso pretreatment reduced Jablonski grade as
compared to the I/R, intralipid and 1 ml/kg EIso groups. *P < 0.05 compared to S, †P < 0.05 compared to I/R, ‡P < 0.05 compared to I, §P < 0.05
compared to EIso 1 ml/kg.
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Cr [26]. In the present study, serum Cr, BUN and CYC
levels in the 2 and 4 ml/kg EIso groups were markedly de-
creased compared with the I/R, intralipid and 1 ml/kg
EIso groups. In addition, the histological scores of renal
injury were significantly decreased with 2 or 4 ml/kg EIso
preconditioning. It showed that both 2 and 4 ml/kg EIso
pretreatment induce protective effects against renal I/R in-
jury in rats.
With renal I/R injury, necrotic cell death results in fur-
ther activation of inflammatory cascades, resulting in more
severe secondary tissue damage [27]. The inflammatory
components consist of TNF-α, IL-6 and IL-8 that cause
leukocytes to accumulate in the vasa recta of the outer me-
dulla [28]. There are growing evidences from in vitro and
in vivo models that the course of renal I/R injury is associ-
ated with intra-renal inflammation, and therefore it is nowrecognized that intra-renal inflammation is deeply in-
volved in the pathogenesis of renal I/R injury [1]. In-
creased levels of renal and serum IL-6 were observed in
mice subjected to renal I/R [29]. And IL-6-knockout mice
suffered less renal I/R injury [30]. The experimental
hyperlipidemia induced by poloxamer 407 decreased renal
I/R injury, which was mediated by reduced renal IL-6
production after the insult [31]. Lee et al. [9] demon-
strated that 1 minimum alveolar concentration isoflurane
given during renal I/R protects against renal I/R injury in
rats by reducing renal TNF-α concentrations and inhibit-
ing nuclear factor-κB activation. Hashiguchi et al. [10] also
showed that 1.5% isoflurane has a preconditioning effect
against rat renal I/R injury when administered 20 min
before ischemia, which may be related to inhibition of
the protein kinases, Jun N-terminal kinase and extracellu-
lar signal-regulated kinase. Recently, pretreatment with
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in mice via upregulation of hypoxia inducible factor-1 α
[12]. In addition, several studies implicated that isoflurane
activates intestinal sphingosine kinase to protect against
renal I/R-induced [8] or bilateral nephrectomy-induced
[32] liver and intestine injury. Other studies suggested that
volatile anesthetics could protect against I/R injury in the
heart [33] and lung [34] via anti-inflammatory effects. IL-
10 is expressed and secreted by a variety of cell types, which
prevents production of proinflammatory cytokines and che-
mokines by monocytes/macrophages. IL-10 is an antiin-
flammatory cytokine which contributes to improvement in
left ventricle functional recovery after myocardial infarction
in a cultured cell study [35]. And IL-10-deficient mice re-
vealed increased neutrophil infiltration, infarct size, and
myocardial necrosis after acute myocardial infarction [36].
In the present study, we demonstrated that both 2 and
4 ml/kg EIso preconditioning significantly reduced the
serum levels of TNF-α and IL-6, increased the serum level
of IL-10 as compared to the I/R, intralipid and 1 ml/kg EIso
groups. Our results indicated that EIso-induced protection
against renal I/R injury was probably related to prevent-
ing inflammatory response. In a recent study, Lv et al.
[18] showed that EIso preconditioning decreased nu-
clear factor-κB activity, TNF-α level, myeloperoxidase
activity, and intercellular adhesion molecule-1 expres-
sion in the lung, which resulted to reduce lung injury
induced by hepatic I/R. Both 2 and 4 ml/kg EIso intra-
venously infused were also found to attenuate myocar-
dial damage by inhibiting apoptosis after ischemia [15].
It is well known that oxygen free radicals contributes
to the pathogenesis of I/R injury. MDA is one of the prod-
ucts of free radical chain reaction and lipid peroxidation.
The changes in tissue MDA content reflect changes in the
quantity of polyunsaturated fatty acid reductions during
I/R injury. Consequently, the increase of MDA content
indicates a lowering of the membrane fluidity and impair-
ment of the normal membrane structure of the mitochon-
dria. SOD is one of important antioxidase that scavenges
oxygen free radicals and protects mitochondria against
damage caused by potentially cytotoxic reactions. Usually
antioxidative ability of tissue is evaluated by MDA content
and SOD activity. Yurdakoc et al. [37] showed that isoflur-
ane could protect against lipid peroxidation of cerebral
injury in rats. Recently, a study demonstrated that EIso in-
creased antioxidation in mitochondria to protect against
liver and lung injury in the rat hemorrhagic shock model
[38]. Similarly, Xu et al. showed that 2 ml/kg EIso pre-
treatment could ameliorate lipopolysaccharide-induced
acute lung injury in rats by decreasing pulmonary MDA
level and increasing pulmonary SOD activity [39]. Our
present study showed that both 2 and 4 ml/kg EIso pre-
conditioning resulted in a decrease of MDA content and
an increase of SOD activity in the kidney tissue. Thesefindings suggested that EIso pretreatment could enhance
renal antioxidative ability, which might be one of mecha-
nisms of renal protection of EIso with 2 or 4 ml/kg, partly
protected against I/R injury.
In the present study, EIso pretreated the kidney with 2
or 4 ml/kg against I/R injury in rats. However, the lower
dose of EIso (1 ml/kg) did not appear to produce protec-
tion, which is consistent with a previous report concern-
ing a dose-dependent effect of isoflurane [40]. There
were no significant differences between the 2 and 4 ml/
kg EIso groups. The similar result was found in the rat
myocardial injury model [15]. Whether formulations
containing higher concentrations or different rates of in-
fusion could be responsible for greater renal protection
deserves further investigation.
EIso is composed of isoflurane and intralipid. As a ve-
hicle, intralipid may influence the renal protection of this
anaesthetic, so the effects of intralipid were also investi-
gated in the present study. It was demonstrated that intrali-
pid preconditioning alone did not protect renal injury.
There is a conflicting report regarding the renal protective
effect of intralipid during acute renal I/R [41]. Several fac-
tors can account for these discrepant results, including dif-
ferences in experimental design, as well as exposure time
and drug concentration. In the present study, there were no
significant differences in these variables between the intrali-
pid and I/R groups with a same experimental protocol.
Therefore, we concluded that the intralipid could be not re-
sponsible for the renal protection of EIso.
There are some limitations of this study, including the
brief period of observation, and one blood and tissue
sampling time point. Moreover, blood concentrations of
isoflurane during infusion and before renal pedicles oc-
clusion were not measured, so unequal doses of isoflur-
ane may administer to rats subjected to renal ischemia.
EIso can be administrated intravenously, which makes
its clinical application more practical than inhalation of
isoflurane. For this reason intravenous EIso may gain
more wider acceptance as a treatment option for clinical
application.Conclusions
In conclusion, the present data demonstrated that intra-
venous administration of EIso before occlusion of the renal
pedicle could afford effective protection against renal I/R,
and attenuate renal proximal tubular dilatation, tubular
epithelial cells swelling, necrosis and sloughing, alleviate
interstitial hemorrhage and edema in rats, which might be
mediated by inhibiting systemic inflammatory response
and improving antioxidation of the tissue.
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